Pons, L.; Hernández, L.; Urbizu, A.; Osorio, P.; RodrÃguez-MartÃnez, P.; Castella, E.; Muñoz, A.; Sanz, C.; Arnaldo, L.; Felip, E.;
et al. Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer. Cancers 2023, 15, 3068.
https://doi.org/10.3390/cancers15123068
AMA Style
Pons L, Hernández L, Urbizu A, Osorio P, RodrÃguez-MartÃnez P, Castella E, Muñoz A, Sanz C, Arnaldo L, Felip E,
et al. Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer. Cancers. 2023; 15(12):3068.
https://doi.org/10.3390/cancers15123068
Chicago/Turabian Style
Pons, Laura, Laura Hernández, Aintzane Urbizu, Paula Osorio, Paula RodrÃguez-MartÃnez, Eva Castella, Ana Muñoz, Carolina Sanz, Laura Arnaldo, Eudald Felip,
and et al. 2023. "Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer" Cancers 15, no. 12: 3068.
https://doi.org/10.3390/cancers15123068
APA Style
Pons, L., Hernández, L., Urbizu, A., Osorio, P., RodrÃguez-MartÃnez, P., Castella, E., Muñoz, A., Sanz, C., Arnaldo, L., Felip, E., Quiroga, V., Tapia, G., MargelÃ, M., & Fernandez, P. L.
(2023). Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer. Cancers, 15(12), 3068.
https://doi.org/10.3390/cancers15123068
